Hims & Hers Health's Options Frenzy: What You Need to Know
Hims & Hers Health, Inc. Class A HIMS | 20.33 20.30 | +6.22% -0.15% Pre |
Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health (NYSE:HIMS).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 20 uncommon options trades for Hims & Hers Health.
This isn't normal.
The overall sentiment of these big-money traders is split between 70% bullish and 10%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $480,663, and 11 are calls, for a total amount of $569,344.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $50.0 for Hims & Hers Health over the recent three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Hims & Hers Health's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims & Hers Health's whale activity within a strike price range from $10.0 to $50.0 in the last 30 days.
Hims & Hers Health Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | CALL | SWEEP | BULLISH | 04/02/26 | $0.9 | $0.89 | $0.89 | $18.00 | $227.6K | 2.8K | 2.6K |
| HIMS | PUT | TRADE | NEUTRAL | 03/20/26 | $25.15 | $22.9 | $24.05 | $40.00 | $74.5K | 711 | 31 |
| HIMS | PUT | TRADE | BULLISH | 12/18/26 | $11.25 | $10.15 | $10.15 | $23.00 | $66.9K | 1.1K | 0 |
| HIMS | PUT | SWEEP | NEUTRAL | 04/17/26 | $7.0 | $6.85 | $6.93 | $22.00 | $65.8K | 86 | 190 |
| HIMS | PUT | TRADE | BEARISH | 04/17/26 | $6.8 | $6.8 | $6.8 | $22.00 | $64.6K | 86 | 95 |
About Hims & Hers Health
Hims & Hers Health Inc operates telehealth platforms, providing access to treatments for various chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. The company connects patients to licensed healthcare professionals who can prescribe medications, with prescriptions fulfilled online through licensed pharmacies. In addition, it offers access to various non-prescription health and wellness products. Through the Hims & Hers mobile applications, the company also offers access to educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Geographically, it derives maximum revenue from the USA.
In light of the recent options history for Hims & Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Hims & Hers Health's Current Market Status
- Trading volume stands at 15,198,429, with HIMS's price down by -6.11%, positioned at $15.47.
- RSI indicators show the stock to be may be oversold.
- Earnings announcement expected in 62 days.
What Analysts Are Saying About Hims & Hers Health
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $27.2.
- An analyst from Morgan Stanley persists with their Equal-Weight rating on Hims & Hers Health, maintaining a target price of $21.
- Maintaining their stance, an analyst from Citigroup continues to hold a Sell rating for Hims & Hers Health, targeting a price of $16.
- An analyst from BTIG persists with their Buy rating on Hims & Hers Health, maintaining a target price of $60.
- Maintaining their stance, an analyst from B of A Securities continues to hold a Underperform rating for Hims & Hers Health, targeting a price of $21.
- An analyst from Leerink Partners has decided to maintain their Market Perform rating on Hims & Hers Health, which currently sits at a price target of $17.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.